Composition of nanoformulated lycopene and method of using the composition
US2016346308A1
Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection
US2016338971A1
Nano co-encapsulation for the prevention and treatment of various disorders
US2016222137A1
Compositions and method for anti-sickling of red blood cells in sickle cell disease
WO2016126450A1
Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis c
US2015223451A1
Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applications
US2015224134A1
Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis C
US2015132399A1
Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis
US2015150818A1
Method and composition of glycosaminoglycans in sickle cell and vascular disorders
US2015140106A1
Ocular nanoformulation and method of use in angiogenesis-mediated disorders
WO2015003025A1
NOVEL FORMULATIONS OF FACTOR VIIa INHIBITORS AND UTILITY
US2014072635A1
Thyroid hormone analogs and methods of use
US2014037722A1
Methods and compositions of camel derived products
US2014017329A1
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
US2013295187A1
Formulations of Factor VIIa inhibitors and utility
US2013149385A1
Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
US8481479B1
Formulations of factor VIIa inhibitors and utility
US2011200673A1
Oxidized heparin fractions and their use in inhibiting angiogenesis
US2011105482A1
Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
US2011104230A1
Compositions of novel bone patch in bone and vascular regeneration
